Hepatitis B-related compensatory cirrhosis
Conditions
Interventions
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Hepatitis B-related compensated cirrhosis patients; (2) Aged 18-65 years old; (3) Patients with TCM syndromes of liver spleen deficiency and damp-heat internal knot; (4) Signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with cirrhosis caused by other causes of chronic liver disease; (2) Acute and chronic hepatitis with non-HBV hepadnavirus infection, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hereditary Metabolic liver disease, drug or toxic hepatitis, alcoholic liver disease patients; (3) pregnant or lactating women and women who plan to be pregnant during the study period; (4) those who are allergic to the test drug; (5) can not cooperate with mental disorders Patients in this study, or patients with unstable epilepsy; (6) Patients with systemic diseases such as severe heart, brain, lung, kidney, and hematopoiesis; (7) Alcoholism or other unsuitable drug test observers, or In combination with treatment, it is difficult to make a definitive evaluation of the effectiveness and safety of the drug; (8) Other circumstances that the investigator believes are not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Annual incidence of liver cancer; | — |
Secondary
| Measure | Time frame |
|---|---|
| HBV-DNA negative conversion rate;liver function;Symptoms;signs;The thickness of spleen; | — |
Countries
China
Contacts
Public ContactWenliang Lv
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed